We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia.
- Authors
Fontana, Joseph A.; Rogers, John S.; Durham, John P.; Fontana, J A; Rogers, J S 2nd; Durham, J P
- Abstract
The addition of retinoic acid to human promyelocytic leukemia cells in culture results in their differentiation to mature myeloid forms with acquisition of the differentiated phenotype, i.e., the ability to reduce nitroblue tetrazolium. A heavily pretreated patient with acute promyelocytic leukemia and residual malignant cells in his marrow after multiple courses of chemotherapy was given 13-cis-retinoic acid upon demonstration of both morphologic and functional differentiation of his leukemic cells by transretinoic acid in vitro. The patient achieved a complete remission and was maintained on 13-cis-retinoic acid for 1 year, when the patient relapsed with a population of cells that were resistant to retinoic acid-induced differentiation.
- Publication
Cancer (0008543X), 1986, Vol 57, Issue 2, p209
- ISSN
0008-543X
- Publication type
journal article
- DOI
10.1002/1097-0142(19860115)57:2<209::AID-CNCR2820570204>3.0.CO;2-K